Feedback / Questions
M2.9 PH1 ADC - Peak Bio
https://www.globenewswire.com/news-release/2024/03/05/2840389/0/en/Akari-Therapeutics-and-Peak-Bio-Announce-Definitive-Agreement-to-Merge-as-Equals-Creating-an-Expanded-Pipeline-That-Features-a-Novel-Antibody-Drug-Conjugate-ADC-Toolkit.html
Mar 5, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next